Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Arctic Bioscience AS ( (DE:9TD) ) is now available.
Arctic Bioscience AS has announced an Extraordinary General Meeting to be held digitally on November 11, 2025, to elect a new auditor due to PwC’s corporate reorganization. This reorganization involves moving Arctic Bioscience to PwC’s wholly owned subsidiary, PwC Assurance AS, with no changes to the services provided, ensuring continuity in their auditing process.
More about Arctic Bioscience AS
Arctic Bioscience is a biotech company focused on developing and commercializing pharmaceutical and nutraceutical products derived from unique bioactive marine compounds. The company is working on HRO350, an oral drug candidate aimed at treating mild-to-moderate psoriasis, and markets nutraceuticals globally under the ROMEGA® brand.
Average Trading Volume: 72,209
Current Market Cap: NOK98.84M
For detailed information about 9TD stock, go to TipRanks’ Stock Analysis page.